Immage Biotherapeutics Corp.

OTC: IMMG · Financial Services · Financial - Conglomerates

PublicHQ Bethesda, Reports USD

#876 of 1,011 Financial Services companies by revenue

EA Score

——

FH —DQ —GM —SS 15

v0.1 · 5/100 weight · pillars only

↑ balance-sheet leverage, disclosure history · ↓ Piotroski F, return on equity

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$216.5k

Employees

Market cap

$15.2k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02016

Net income-$216.5k-$216.5k2016

Operating income-$216.5k-$216.5k2016

Total assets$243.1k$243.1k2016

Liabilities$55.8k$55.8k2016

Equity$187.3k$187.3k2016

Revenue trend

FY2012 – FY2016 · USD

FY12

FY13

FY14

FY15

FY16

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Immage Biotherapeutics Corp. booked $0 in FY2016 revenue — among the slowest-growing Financial Services companies we track, at a -Infinity% net margin.

Peers · Financial Services

China De Xiao Quan Care Group Co., Ltd——Starrex International Ltd.——Xynergy Holdings, Inc.——Crown Baus Capital Corp.——

Key facts

CEOZhi Cong Mou

SectorFinancial Services

IndustryFinancial - Conglomerates

HeadquartersBethesda, null

ExchangeOTC: IMMG

Employees3

IPO date2022-12-02

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.